As per MRFR analysis, the US Thyroid Test Market Size was estimated at 410.19 (USD Million) in 2023. The US Thyroid Test Market Industry is expected to grow from 433.65(USD Million) in 2024 to 979.13 (USD Million) by 2035. The US Thyroid Test Market CAGR (growth rate) is expected to be around 7.685% during the forecast period (2025 - 2035).
The US Thyroid Test Market is experiencing notable trends that reflect the increasing awareness and demand for thyroid health assessments. A key market driver includes the rising prevalence of thyroid disorders, commonly diagnosed through laboratory tests and often requiring ongoing monitoring. The American Thyroid Association reports that millions of Americans are affected by conditions such as hypothyroidism and hyperthyroidism, driving the need for efficient testing solutions.
There are also significant opportunities to be explored in telemedicine and home testing kits. With the ongoing digital transformation in healthcare, patients are increasingly seeking convenient testing options that can be conducted from the comfort of their homes. This trend is fueled by advancements in technology and a growing consumer preference for personalized healthcare solutions.
Recently, there has been a surge in the development of more sensitive and specific testing methods, enhancing the accuracy of thyroid function assessments. The introduction of innovative biomarkers and automated testing systems is streamlining processes and reducing the turnaround time for test results.
Additionally, educational initiatives by healthcare organizations are further promoting awareness about thyroid health and the importance of regular screening, contributing to higher testing rates. These trends highlight a dynamic landscape in the US Thyroid Test Market, driven by both consumer demands and technological advancements, positioning stakeholders for substantial growth and engagement in the coming years.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The increasing prevalence of thyroid disorders in the United States is a significant driver for the US Thyroid Test Market Industry. According to the American Thyroid Association, it is estimated that approximately 20 million Americans have some form of thyroid disease, with 60% of those unaware of their condition. The rising awareness and diagnosis of these disorders will drive demand for thyroid testing.
Additionally, the Centers for Disease Control and Prevention has reported that thyroid function tests, such as thyroid stimulating hormone (TSH) tests, represent a crucial aspect of healthcare for individuals over 35 years old, highlighting the need for comprehensive screening programs. Such statistics indicate a growing market where proactive healthcare measures are being implemented, subsequently increasing the market for thyroid tests in the U.S.
Advancements in technology related to diagnostic tools have significantly impacted the US Thyroid Test Market Industry. Recent innovations in high-throughput screening methods and the development of more sensitive assays for thyroid hormones enable quicker and more accurate diagnosis.
According to the U.S. Food and Drug Administration, the approval of innovative diagnostic devices has facilitated an increase in the number of tests being performed in the U.S., with a reported annual growth rate of about 6% in the adoption of advanced testing technologies. This technological evolution is not only enhancing diagnostic accuracy but also expanding the range of available tests, which contributes positively to the market growth.
There is a growing trend towards preventive healthcare in the United States, which is notably influencing the US Thyroid Test Market Industry. Educational campaigns and programs aimed at raising public awareness about thyroid health are becoming more common.
The U.S. Department of Health and Human Services has emphasized the importance of preventive services, including regular thyroid screenings, especially among high-risk populations. This shift in focus towards prevention is reflected in studies showing that about 50% of patients diagnosed with thyroid conditions had undergone testing following awareness campaigns. The increased public demand for such preventative measures can significantly bolster the market for thyroid testing services.
The US Thyroid Test Market is characterized by its diverse Type segmentation, which includes categories such as TSH Tests, T4 Tests, T3 Tests, and Other tests. Each of these segments plays a vital role in diagnosing and managing thyroid conditions, which have become increasingly prevalent in the United States. With a growing awareness of thyroid disorders among the population, the demand for these tests is witnessing significant growth.
Among these, TSH (Thyroid Stimulating Hormone) tests are particularly notable due to their widespread use as the initial screening tool for thyroid dysfunctions. They help assess the pituitary gland's role in regulating thyroid hormone production, making them crucial in both diagnosing hypothyroidism and hyperthyroidism.
The T4 tests, which measure the levels of Thyroxine in the bloodstream, are also critical as they provide insights into the thyroid's overall function and hormone output. Given that T4 is a key hormone produced by the thyroid gland, these tests often complement TSH tests, allowing healthcare providers to form a comprehensive overview of thyroid health.
In contrast, T3 tests measure the Triiodothyronine hormone levels, and while they are less commonly ordered than TSH and T4 tests, they are essential for certain cases, particularly in evaluating hyperthyroidism. The Other segment typically includes various specialized tests and procedures that may need to be conducted for more complex cases or rare conditions affecting the thyroid.
As healthcare organizations in the United States continue to emphasize preventive care and early diagnosis, the importance of thyroid tests is increasingly recognized. Factors driving the growth of the US Thyroid Test Market include an aging population, heightened incidence of thyroid diseases, and advancements in laboratory technology. With more accurate and efficient testing methods emerging, healthcare providers are equipped to make better-informed decisions, which in turn enhances patient outcomes. Furthermore, the rise in health awareness campaigns and improved access to healthcare facilities are contributing to increased testing rates across all segments, thereby positively impacting the overall US Thyroid Test Market revenue. Such dynamics underscore the importance of understanding the market segmentation, as each segment plays a significant role in addressing the thyroid health needs of the population.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
In the US Thyroid Test Market, the End User segment plays a crucial role in determining the overall demand and application of thyroid testing. The market is primarily divided among Hospitals, Diagnostic Laboratories, and Research Laboratories and Institutes, each serving different functions and needs.
Hospitals are essential in providing immediate and comprehensive healthcare services, often being the first point of contact for patients requiring thyroid evaluations. Diagnostic Laboratories are significant as they handle a substantial volume of tests, ensuring accuracy and reliability in results, which is essential for patient diagnosis and treatment decisions.
Research Laboratories and Institutes contribute to the advancement of thyroid research, enabling the development of new and innovative testing methods, thereby driving the overall market growth. The increasing prevalence of thyroid disorders and advancements in healthcare technology are key growth drivers within this segment.
Moreover, rising awareness about thyroid health and the availability of advanced diagnostic solutions further solidify the market's potential. The emphasis on accurate diagnostics in these various End User categories underscores their importance in the healthcare ecosystem, ultimately ensuring that the growing demand for thyroid testing is met effectively.
The US Thyroid Test Market has seen significant growth driven by increasing awareness of thyroid-related disorders and advancements in diagnostic technologies. This market is characterized by a diverse range of players offering various testing solutions, including blood tests, imaging studies, and genetic assessments.
As the prevalence of thyroid diseases such as hypothyroidism and hyperthyroidism continues to rise, the demand for timely and accurate testing has become paramount. The competitive landscape is shaped by several factors including innovation in testing methodologies, regulatory advancements, partnerships, and mergers and acquisitions that enhance service delivery and expand market reach.
Companies in this sector are actively engaging in research and development to refine existing tests and create new ones that can provide faster and more accurate results for healthcare providers and patients.
Laboratory Corporation of America Holdings has emerged as a frontrunner in the US Thyroid Test Market, leveraging its extensive laboratory network and state-of-the-art technology to deliver comprehensive testing solutions. The company has built a robust presence by focusing on providing high-quality services that physicians and patients can rely on for accurate thyroid diagnostics.
Their strengths include a wide-ranging test menu, quick turnaround times, and a commitment to leveraging cutting-edge technology in laboratory processes. Laboratory Corporation of America Holdings has established numerous partnerships and collaborations with healthcare providers and institutions, enabling them to broaden their testing capabilities and reinforce their market share. Their proficiency in automating laboratory processes allows for enhanced efficiency and reliability, making them a preferred choice among healthcare professionals.
BioRad Laboratories holds a significant position in the US Thyroid Test Market, known for its innovative products and commitment to advancing diagnostic solutions. The company offers an array of key products and services tailored to thyroid testing, which include high-quality assays and reagents that help in the precise diagnosis of thyroid dysfunctions.
BioRad's strengths lie in its advanced research and development capabilities, which facilitate the continuous improvement of its testing offerings. The company's strategic intent often involves merging or acquiring smaller firms or technologies to bolster its portfolio, thereby enhancing its competitive edge in the market. BioRad has successfully maintained a significant market presence thanks to its dedication to quality, reliability, and innovation, which resonate well with customer needs in the US healthcare landscape. By constantly evolving its approach to service delivery and product development, BioRad Laboratories stands as a strong competitor in the thyroid testing segment within the United States.
The US Thyroid Test Market has seen significant developments, particularly with advancements in testing technologies and increased emphasis on early diagnosis of thyroid disorders. In September 2023, Laboratory Corporation of America Holdings expanded its test offerings to include advanced thyroid function tests, reflecting growing consumer demand for comprehensive health screenings.
Abbott Laboratories has also made strides by launching an innovative point-of-care test aimed at improving the speed of diagnosis for thyroid disorders. On the acquisition front, in August 2023, Thermo Fisher Scientific announced its acquisition of a diagnostics company focused on specialized thyroid testing, enhancing its product portfolio. Additionally, Quest Diagnostics reported a notable increase in service demand, driving growth in market valuations.
Over the past two to three years, companies like F. Hoffmann-La Roche AG and Siemens Healthineers have invested heavily in Research and Development to launch next-generation assays that improve accuracy in thyroid testing. The surge in thyroid conditions and the growing awareness among healthcare providers and patients are anticipated to propel market growth further, complemented by technological enhancements and the introduction of innovative testing solutions.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 410.19(USD Million) |
| MARKET SIZE 2024 | 433.65(USD Million) |
| MARKET SIZE 2035 | 979.13(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.685% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Laboratory Corporation of America Holdings, BioRad Laboratories, Roche Diagnostics, Eastside Clinical Laboratory, Abbott Laboratories, PerkinElmer, Thermo Fisher Scientific, Genova Diagnostics, Siemens Healthineers, Quest Diagnostics, F. HoffmannLa Roche AG, Ortho Clinical Diagnostics, DiaSorin |
| SEGMENTS COVERED | Type, End User |
| KEY MARKET OPPORTUNITIES | Innovative diagnostic technologies, Growing prevalence of thyroid disorders, Increased awareness and education, Home testing kits demand, Personalized medicine advancements |
| KEY MARKET DYNAMICS | Increasing prevalence of thyroid disorders, Growing awareness of thyroid disease, Expanding diagnostics innovations, Rising elderly population, Advancements in laboratory technology |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Thyroid Test Market is valued at approximately 433.65 million USD in 2024.
The market is expected to grow at a compound annual growth rate (CAGR) of 7.685 percent from 2025 to 2035.
By 2035, the US Thyroid Test Market is projected to reach a value of 979.13 million USD.
The TSH Tests segment dominates the market with an expected value of 335.0 million USD by 2035.
The market size for T4 Tests is valued at 120.0 million USD in 2024.
Major players include Laboratory Corporation of America Holdings, BioRad Laboratories, Roche Diagnostics, and Quest Diagnostics among others.
The T3 Tests segment is expected to reach a market value of 160.0 million USD by 2035.
The 'Other' category is estimated to have a market value of 88.65 million USD in 2024.
Key trends include increasing awareness of thyroid disorders and advancements in testing technologies.
Challenges may include regulatory hurdles and the need for improved testing accuracy and accessibility.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
